On Oct. 22, 2026, Anthropic is inviting members of the life sciences community to apply to work with…
On Oct. 19, 2026, the Associated Press has reported that when the Trump administration began upending U.S. scientific…
On Oct. 14, 2026, this fall, the Massachusetts Institute of Technology, where 95% of students are STEM majors,…
On Sept. 17, 2026, Ultragenyx Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) granted standard full…
On Sept. 15, 2026, the U.S. Food and Drug Administration announced the final design of the Expedited Investigational…
On Sept. 3, 2026, Ionis Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved ZANVASTRO™…
On Aug. 19, 2026, Ultragenyx Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) has granted accelerated…
On Aug. 18, 2026, BioMarin Pharmaceutical announced a definitive agreement to acquire Alesta Therapeutics to gain Alesta’s lead…
On Aug. 10, 2026, Chinese researchers have created an open-source AI system capable of bridging the gap between…
On Jul. 3, 2026, a research team led by Helmholtz Munich and Ludwig Maximilian University has developed TAPIR,…
On Jun. 8, 2026, Incyte announced it has entered into a definitive agreement to acquire Vega Therapeutics, a wholly owned…
On Apr. 8, 2026, the Trump administration will not be asking the Supreme Court to take up its…
On Mar. 31, 2026, Biogen and Apellis Pharmaceuticals announced the companies have entered into a definitive agreement under…
On Mar. 27, 2026, a STAT survey conducted of nearly 1,000 National Institutes of Health (NIH) -supported scientists,…
On Mar. 27, 2026, Rocket Pharmaceuticals announced that the U.S. Food and Drug Administration(FDA) has granted accelerated approval…
On Mar. 18, 2026, the National Institutes of Health (NIH) announced more than $150 million to develop and…
On Feb. 24, 2026, Womb Transplant UK announced in an historic breakthrough, that a bouncing baby boy has…
On Jan. 14, 2026, U.S. healthcare spending rose by 7.2% to $5.3 trillion in 2024 from $4.9 trillion…
On Jan. 8, 2026, researchers reported results from a study on the largest cohort of autobrewery syndrome (ABS)…
On Dec. 19, 2025, BioMarin Pharmaceutical and Amicus Therapeutics announced that BioMarin has entered into a definitive agreement…
On Dec. 15, 2025, the U.S. National Institutes of Health is seeking to fill nearly half of its…
On Dec. 11, 2025, the California Institute for Regenerative Medicine (CIRM) governing board approved funding of over $160…
On Nov. 24, 2025, a new AI model called popEVE developed by Harvard Medical School researchers and colleagues…
On Nov. 20, 2025, the Institute for Research on Innovation and Science (IRIS) released a report that demonstrates…
On Nov. 20, 2025, the National Institutes of Health (NIH) has canceled funding for at least 383 clinical…
On Nov. 18, 2025, Arrowhead Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved REDEMPLO…
On Nov. 17, 2025, a JAMA published study found that more than 74,000 people have had their lives…
On Oct. 15, 2025, Danish drugmaker Novo Nordisk and Omeros announced they have signed a licensing deal worth…
On Jul. 9, 2025, as part of a new study, neurologists at NYU Langone Health announced they have…
On Jun. 5, 2025, the final studies from the recently shuttered National Institute of Allergy and Infectious Diseases’…